• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从环境到细胞:影响 COVID-19 大流行中传播和感染的关键因素概述。

From the environment to the cells: An overview on pivotal factors which affect spreading and infection in COVID-19 pandemic.

机构信息

Department of Food Science and Technology, School of Industrial Technology, Faculty of Applied Sciences, Universiti Teknologi MARA, 40450, Shah Alam, Selangor, Malaysia.

Department of Molecular Biology and Genetics, Gene Expression and Gene Medicine, Aarhus University, Aarhus, Denmark.

出版信息

Environ Res. 2021 Oct;201:111555. doi: 10.1016/j.envres.2021.111555. Epub 2021 Jun 28.

DOI:10.1016/j.envres.2021.111555
PMID:34197816
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8236413/
Abstract

Several factors ranging from environmental risks to the genetics of the virus and that of the hosts, affect the spread of COVID-19. The impact of physicochemical variables on virus vitality and spread should be taken into account in experimental and clinical studies. Another avenue to explore is the effect of diet and its interaction with the immune system on SARS-CoV-2 infection and mortality rate. Past year have witnessed extensive studies on virus and pathophysiology of the COVID-19 disease and the cellular mechanisms of virus spreading. However, our knowledge has not reached a level where we plan an efficient therapeutic approach to prevent the virus entry to the cells or decreasing the spreading and morbidity in severe cases of disease. The risk of infection directly correlates with the control of virus spreading via droplets and aerosol transmission, as well as patient immune system response. A key goal in virus restriction and transmission rate is to understand the physicochemical structure of aerosol and droplet formation, and the parameters that affect the droplet-borne and airborne in different environmental conditions. The lifetime of droplets on different surfaces is described based on the contact angle. Hereby, we recommend regular use of high-quality face masks in high temperature and low humidity conditions. However, in humid and cold weather conditions, wearing gloves and frequently hand washing, gain a higher priority. Additionally, social distancing rules should be respected in all aforementioned conditions. We will also discuss different routes of SARS-CoV-2 entry into the cells and how multiple genetic factors play a role in the spread of the virus. Given the role of environmental and nutritional factors, we discuss and recommend some strategies to prevent the disease and protect the population against COVID-19. Since an effective vaccine can prevent the transmission of communicable diseases and abolish pandemics, we added a brief review of candidate SARS-CoV-2 vaccines.

摘要

从环境风险到病毒和宿主的遗传因素,有几个因素会影响 COVID-19 的传播。在实验和临床研究中,应该考虑物理化学变量对病毒活力和传播的影响。另一个值得探索的途径是饮食及其与免疫系统相互作用对 SARS-CoV-2 感染和死亡率的影响。过去一年见证了对病毒和 COVID-19 疾病病理生理学以及病毒传播的细胞机制的广泛研究。然而,我们的知识还没有达到可以制定有效治疗方法的水平,以防止病毒进入细胞,或减少疾病严重病例中的传播和发病率。感染的风险与通过飞沫和气溶胶传播以及患者免疫系统反应来控制病毒传播直接相关。限制病毒和降低传播率的一个关键目标是了解气溶胶和液滴形成的物理化学结构,以及影响不同环境条件下飞沫和空气传播的参数。不同表面上的液滴寿命基于接触角来描述。因此,我们建议在高温低湿度条件下定期使用高质量的口罩。然而,在潮湿寒冷的天气条件下,戴手套和经常洗手就显得更为重要。此外,在上述所有条件下都应遵守保持社交距离的规则。我们还将讨论 SARS-CoV-2 进入细胞的不同途径以及多种遗传因素如何在病毒传播中发挥作用。鉴于环境和营养因素的作用,我们讨论并建议了一些预防疾病和保护人群免受 COVID-19 侵害的策略。由于有效的疫苗可以预防传染病的传播并消除大流行,因此我们还简要回顾了 SARS-CoV-2 候选疫苗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2b0/8236413/82100d72ca7c/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2b0/8236413/dee0ca89d0c8/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2b0/8236413/e426774c04c1/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2b0/8236413/c531b47d9a34/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2b0/8236413/82100d72ca7c/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2b0/8236413/dee0ca89d0c8/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2b0/8236413/e426774c04c1/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2b0/8236413/c531b47d9a34/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2b0/8236413/82100d72ca7c/gr3_lrg.jpg

相似文献

1
From the environment to the cells: An overview on pivotal factors which affect spreading and infection in COVID-19 pandemic.从环境到细胞:影响 COVID-19 大流行中传播和感染的关键因素概述。
Environ Res. 2021 Oct;201:111555. doi: 10.1016/j.envres.2021.111555. Epub 2021 Jun 28.
2
Analytic modeling and risk assessment of aerial transmission of SARS-CoV-2 virus through vaping expirations in shared micro-environments.在共享微环境中通过蒸发气溶胶吸入途径分析 SARS-CoV-2 病毒空气传播的建模与风险评估
Environ Sci Pollut Res Int. 2022 Nov;29(55):83020-83044. doi: 10.1007/s11356-022-20499-1. Epub 2022 Jun 27.
3
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.新冠病毒-19(Sars-Cov-2)的英国变体不应造成疫苗问题。
J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E.
4
Effectiveness of Face Masks in Preventing Airborne Transmission of SARS-CoV-2.口罩预防 SARS-CoV-2 空气传播的有效性。
mSphere. 2020 Oct 21;5(5):e00637-20. doi: 10.1128/mSphere.00637-20.
5
Should face masks be worn to contain the spread of COVID-19 in the postlockdown phase?戴口罩是否能在封锁阶段后遏制 COVID-19 的传播?
Trans R Soc Trop Med Hyg. 2021 Jan 7;115(1):74-77. doi: 10.1093/trstmh/traa085.
6
Community Use of Face Masks against the Spread of COVID-19.社区使用口罩预防 COVID-19 的传播。
Int J Environ Res Public Health. 2021 Mar 19;18(6):3214. doi: 10.3390/ijerph18063214.
7
Knowledge and practice of personal protective measures during the COVID-19 pandemic: A cross-sectional study in Saudi Arabia.《COVID-19 大流行期间个人防护措施的知识和实践:沙特阿拉伯的一项横断面研究》
PLoS One. 2020 Dec 11;15(12):e0243695. doi: 10.1371/journal.pone.0243695. eCollection 2020.
8
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.新型冠状病毒病 2019(COVID-19)的病理生理学、传播、诊断和治疗:综述。
JAMA. 2020 Aug 25;324(8):782-793. doi: 10.1001/jama.2020.12839.
9
Transmission and prevention of SARS-CoV-2.SARS-CoV-2 的传播与预防。
Biochem Soc Trans. 2020 Oct 30;48(5):2307-2316. doi: 10.1042/BST20200693.
10
Airborne Transmission Route of COVID-19: Why 2 Meters/6 Feet of Inter-Personal Distance Could Not Be Enough.新冠病毒的空气传播途径:为什么 2 米/6 英尺的人际距离还不够。
Int J Environ Res Public Health. 2020 Apr 23;17(8):2932. doi: 10.3390/ijerph17082932.

引用本文的文献

1
Diversity in the Clinical Course and Outcome of COVID-19 in Patients with Different Inborn Errors of Immunity can be Associated with the Type of Error.不同先天性免疫缺陷患者中新冠病毒病临床病程和结局的多样性可能与缺陷类型有关。
Adv Biomed Res. 2024 Nov 30;13:112. doi: 10.4103/abr.abr_134_23. eCollection 2024.
2
Ecosystem degradation and the spread of Covid-19.生态系统退化与新冠病毒传播。
Environ Monit Assess. 2023 Jun 13;195(7):836. doi: 10.1007/s10661-023-11403-6.
3
Lockdown Amid COVID-19 Ascendancy over Ambient Particulate Matter Pollution Anomaly.

本文引用的文献

1
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial.灭活新冠病毒疫苗BBV152的安全性和免疫原性:一项双盲、随机、多中心2期试验的中期结果以及一项双盲、随机1期试验的3个月随访
Lancet Infect Dis. 2021 Jul;21(7):950-961. doi: 10.1016/S1473-3099(21)00070-0. Epub 2021 Mar 8.
2
Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19.COVID-19 用 Ad26.COV2.S 疫苗的免疫原性。
JAMA. 2021 Apr 20;325(15):1535-1544. doi: 10.1001/jama.2021.3645.
3
An interactive website tracking COVID-19 vaccine development.
新冠疫情期间,大气颗粒物污染异常攀升,城市实施封锁措施。
Int J Environ Res Public Health. 2022 Oct 19;19(20):13540. doi: 10.3390/ijerph192013540.
4
Environment and COVID-19 incidence: A critical review.环境与 COVID-19 发病关系的研究进展。
J Environ Sci (China). 2023 Feb;124:933-951. doi: 10.1016/j.jes.2022.02.016. Epub 2022 Feb 21.
一个追踪新冠疫苗研发情况的交互式网站。
Lancet Glob Health. 2021 May;9(5):e590-e592. doi: 10.1016/S2214-109X(21)00043-7. Epub 2021 Mar 2.
4
Covid-19: Where are we on vaccines and variants?新冠疫情:我们在疫苗和病毒变种方面进展如何?
BMJ. 2021 Mar 2;372:n597. doi: 10.1136/bmj.n597.
5
COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.COVID-19 疫苗:辉瑞/生物科技和 Moderna 疫苗的生物学、药理学特征和不良反应比较。
Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1663-1669. doi: 10.26355/eurrev_202102_24877.
6
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.一剂接种和加强针接种时间对 ChAdOx1 nCoV-19(阿斯利康)疫苗免疫原性和有效性的影响:四项随机试验的 pooled 分析。
Lancet. 2021 Mar 6;397(10277):881-891. doi: 10.1016/S0140-6736(21)00432-3. Epub 2021 Feb 19.
7
Immunotherapy for COVID-19: Evolving treatment of viral infection and associated adverse immunological reactions.2019冠状病毒病的免疫疗法:病毒感染及相关不良免疫反应的治疗进展
Transfus Apher Sci. 2021 Apr;60(2):103093. doi: 10.1016/j.transci.2021.103093. Epub 2021 Feb 13.
8
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial.一种灭活严重急性呼吸综合征冠状病毒2疫苗(科兴新冠疫苗)在60岁及以上健康成年人中的安全性、耐受性和免疫原性:一项随机、双盲、安慰剂对照的1/2期临床试验
Lancet Infect Dis. 2021 Jun;21(6):803-812. doi: 10.1016/S1473-3099(20)30987-7. Epub 2021 Feb 3.
9
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia.基于 rAd26 和 rAd5 载体的异源初免-加强型 COVID-19 疫苗的安全性和有效性:俄罗斯一项随机对照 3 期临床试验的中期分析。
Lancet. 2021 Feb 20;397(10275):671-681. doi: 10.1016/S0140-6736(21)00234-8. Epub 2021 Feb 2.
10
Lipid Nanoparticles as Delivery Systems for RNA-Based Vaccines.脂质纳米颗粒作为基于RNA疫苗的递送系统
Pharmaceutics. 2021 Feb 2;13(2):206. doi: 10.3390/pharmaceutics13020206.